OPKO Health Share Holder Equity 2010-2024 | OPK

OPKO Health share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
OPKO Health Annual Share Holder Equity
(Millions of US $)
2023 $1,389
2022 $1,562
2021 $1,685
2020 $1,672
2019 $1,615
2018 $1,791
2017 $1,844
2016 $2,092
2015 $1,980
2014 $836
2013 $873
2012 $179
2011 $161
2010 $23
2009 $32
OPKO Health Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $1,403
2024-06-30 $1,395
2024-03-31 $1,253
2023-12-31 $1,389
2023-09-30 $1,445
2023-06-30 $1,535
2023-03-31 $1,552
2022-12-31 $1,562
2022-09-30 $1,629
2022-06-30 $1,719
2022-03-31 $1,615
2021-12-31 $1,685
2021-09-30 $1,766
2021-06-30 $1,743
2021-03-31 $1,697
2020-12-31 $1,672
2020-09-30 $1,624
2020-06-30 $1,588
2020-03-31 $1,549
2019-12-31 $1,615
2019-09-30 $1,642
2019-06-30 $1,709
2019-03-31 $1,763
2018-12-31 $1,791
2018-09-30 $1,789
2018-06-30 $1,810
2018-03-31 $1,823
2017-12-31 $1,844
2017-09-30 $2,089
2017-06-30 $2,107
2017-03-31 $2,107
2016-12-31 $2,092
2016-09-30 $2,105
2016-06-30 $2,016
2016-03-31 $1,998
2015-12-31 $1,980
2015-09-30 $1,969
2015-06-30 $827
2015-03-31 $813
2014-12-31 $836
2014-09-30 $887
2014-06-30 $913
2014-03-31 $831
2013-12-31 $873
2013-09-30 $868
2013-06-30 $312
2013-03-31 $320
2012-12-31 $179
2012-09-30 $146
2012-06-30 $152
2012-03-31 $155
2011-12-31 $161
2011-09-30 $102
2011-06-30 $111
2011-03-31 $124
2010-12-31 $23
2010-09-30 $20
2010-06-30 $50
2010-03-31 $56
2009-12-31 $32
2009-09-30 $64
2009-06-30 $39
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.106B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.062B 26.20
Intuitive Surgical (ISRG) United States $209.612B 96.16
Alcon (ALC) Switzerland $45.206B 30.25
Edwards Lifesciences (EW) United States $41.870B 26.59
IQVIA Holdings (IQV) United States $38.108B 20.48
IDEXX Laboratories (IDXX) United States $37.713B 43.16
DexCom (DXCM) United States $34.497B 51.95
Mettler-Toledo (MTD) United States $28.642B 32.97
Waters (WAT) United States $24.401B 36.08
STERIS (STE) Ireland $22.253B 25.33
SONOVA HOLDING (SONVY) Switzerland $20.160B 0.00
Hologic (HOLX) United States $14.774B 15.85
Fresenius Medical Care AG KGaA (FMS) Germany $14.260B 14.64
Globus Medical (GMED) United States $11.976B 30.33
Sysmex ADR (SSMXY) Japan $11.771B 36.91
Penumbra (PEN) United States $10.036B 98.31
Masimo (MASI) United States $9.638B 46.64
Glaukos (GKOS) United States $8.562B 0.00
Teleflex (TFX) United States $8.064B 12.86
Integer Holdings (ITGR) United States $4.726B 26.79
Inari Medical (NARI) United States $4.676B 0.00
PROCEPT BioRobotics (PRCT) United States $3.694B 0.00
Veracyte (VCYT) United States $3.371B 101.16
Nihon Kohden (NHNKY) Japan $2.700B 14.76
LivaNova (LIVN) United Kingdom $2.605B 15.04
TransMedics (TMDX) United States $2.467B 78.19
Tandem Diabetes Care (TNDM) United States $2.413B 0.00
Elekta AB (EKTAY) Sweden $2.332B 20.97
Integra LifeSciences Holdings (IART) United States $2.008B 10.49
Alphatec Holdings (ATEC) United States $1.620B 0.00
RxSight (RXST) United States $1.353B 0.00
Pulse Biosciences (PLSE) United States $1.340B 0.00
Artivion (AORT) United States $1.311B 86.86
Paragon 28 (FNA) United States $1.088B 0.00
AxoGen (AXGN) United States $0.807B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.781B 13.27
IRadimed (IRMD) United States $0.778B 42.03
Mesa Laboratories (MLAB) United States $0.770B 16.83
SiBone (SIBN) United States $0.725B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.706B 0.00
Treace Medical Concepts (TMCI) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.574B 0.00
Delcath Systems (DCTH) United States $0.526B 0.00
ClearPoint Neuro (CLPT) United States $0.521B 0.00
Semler Scientific (SMLR) United States $0.463B 24.35
AngioDynamics (ANGO) United States $0.449B 0.00
Pacific Biosciences Of California (PACB) United States $0.438B 0.00
Tactile Systems Technology (TCMD) United States $0.412B 22.30
NeuroPace (NPCE) United States $0.408B 0.00
CVRx (CVRX) United States $0.357B 0.00
Accuray (ARAY) United States $0.277B 0.00
Inogen (INGN) United States $0.258B 0.00
Alpha Tau Medical (DRTS) Israel $0.226B 0.00
Anteris Technologies Global (AVR) Australia $0.222B 0.00
KORU Medical Systems (KRMD) United States $0.222B 0.00
Nevro (NVRO) United States $0.214B 0.00
Sight Sciences (SGHT) United States $0.138B 0.00
Rapid Micro Biosystems (RPID) United States $0.133B 0.00
LENSAR (LNSR) United States $0.126B 0.00
Hyperfine (HYPR) United States $0.125B 0.00
Spectral Diagnostics (EDTXF) Canada $0.118B 0.00
Neuronetics (STIM) United States $0.108B 0.00
Atossa Genetics (ATOS) United States $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.100B 15.20
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.081B 0.00
InspireMD (NSPR) Israel $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.061B 31.57
Lucid Diagnostics (LUCD) United States $0.057B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Positron (POSC) United States $0.053B 0.00
Microbot Medical (MBOT) United States $0.044B 0.00
Baird Medical Investment Holdings (BDMD) $0.039B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
WORK Medical Technology Group (WOK) China $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
NexGel (NXGL) United States $0.023B 0.00
DarioHealth (DRIO) United States $0.021B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00